EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolisation

GILLMORE, Roopinder ; STUART, Sam ; KIRKWOOD, Amy ; HAMEEDUDDIN, Ayshea ; WOODWARD, Nick ; BURROUGHS, Andrew K ; MEYER, Tim

Journal of hepatology, 2011-12, Vol.55 (6), p.1309-1316 [Periódico revisado por pares]

Kidlington: Elsevier

Texto completo disponível